115 related articles for article (PubMed ID: 15231655)
1. Genotoxicity of therapeutic intervention in children with acute lymphocytic leukemia.
Rice SC; Vacek P; Homans AH; Messier T; Rivers J; Kendall H; Finette BA
Cancer Res; 2004 Jul; 64(13):4464-71. PubMed ID: 15231655
[TBL] [Abstract][Full Text] [Related]
2. Analysis of microsatellite instability in children treated for acute lymphocytic leukemia with elevated HPRT mutant frequencies.
Kendall HE; Vacek PM; Finette BA
Mutagenesis; 2004 Sep; 19(5):409-12. PubMed ID: 15388815
[TBL] [Abstract][Full Text] [Related]
3. Analysis of genetic alterations and clonal proliferation in children treated for acute lymphocytic leukemia.
Kendall HE; Vacek PM; Rivers JL; Rice SC; Messier TL; Finette BA
Cancer Res; 2006 Sep; 66(17):8455-61. PubMed ID: 16951156
[TBL] [Abstract][Full Text] [Related]
4. Comparative analysis of HPRT mutant frequency in children with cancer.
Rice SC; Vacek PM; Homans AH; Kendall H; Rivers J; Messier T; Finette BA
Environ Mol Mutagen; 2003; 42(1):44-9. PubMed ID: 12874812
[TBL] [Abstract][Full Text] [Related]
5. Treatment of acute lymphoblastic leukaemia in countries with limited resources; lessons from use of a single protocol in India over a twenty year period [corrected].
Magrath I; Shanta V; Advani S; Adde M; Arya LS; Banavali S; Bhargava M; Bhatia K; Gutiérrez M; Liewehr D; Pai S; Sagar TG; Venzon D; Raina V
Eur J Cancer; 2005 Jul; 41(11):1570-83. PubMed ID: 16026693
[TBL] [Abstract][Full Text] [Related]
6. Level of tau protein in children treated for acute lymphoblastic leukemia.
Muszyńska-Rosłan K; Krawczuk-Rybak M; Protas PT; Hołownia A
Pediatr Neurol; 2006 May; 34(5):367-71. PubMed ID: 16647996
[TBL] [Abstract][Full Text] [Related]
7. Somatic mutant frequency at the HPRT locus in children associated with a pediatric cancer cluster linked to exposure to two superfund sites.
Vacek PM; Messier T; Rivers J; Sullivan L; O'Neill JP; Finette BA
Environ Mol Mutagen; 2005 May; 45(4):339-45. PubMed ID: 15657919
[TBL] [Abstract][Full Text] [Related]
8. [Accretion of bone mass in patients treated for childhood acute lymphoblastic leukemia].
Muszyńska-Rosłan K; Konstantynowicz J; Krawczuk-Rybak M
Pol Merkur Lekarski; 2007 Oct; 23(136):271-5. PubMed ID: 18293849
[TBL] [Abstract][Full Text] [Related]
9. Chemotherapy and attentional dysfunction in survivors of childhood acute lymphoblastic leukemia: effect of treatment intensity.
Buizer AI; de Sonneville LM; van den Heuvel-Eibrink MM; Veerman AJ
Pediatr Blood Cancer; 2005 Sep; 45(3):281-90. PubMed ID: 15806539
[TBL] [Abstract][Full Text] [Related]
10. Surprise at genotoxicity findings for childhood leukaemia therapy.
Whelan J
Drug Discov Today; 2004 Sep; 9(17):731-2. PubMed ID: 15450234
[No Abstract] [Full Text] [Related]
11. Obesity and hypertension among children after treatment for acute lymphoblastic leukemia.
Chow EJ; Pihoker C; Hunt K; Wilkinson K; Friedman DL
Cancer; 2007 Nov; 110(10):2313-20. PubMed ID: 17896787
[TBL] [Abstract][Full Text] [Related]
12. [Preliminary results of the use of MRD test among children with acute lymphoblastic leukaemia].
Raciborska A; Wypych A; Rokicka-Milewska R; Siedlecki JA; Kulik J
Przegl Lek; 2004; 61 Suppl 2():62-6. PubMed ID: 15686049
[TBL] [Abstract][Full Text] [Related]
13. Analysis of hprt gene mutation following anti-cancer treatment in pediatric patients with acute leukemia.
Hirota H; Kubota M; Hashimoto H; Adachi S; Matsubara K; Kuwakado K; Akiyama Y; Tsutsui T; Mikawa H
Mutat Res; 1993 Oct; 319(2):113-20. PubMed ID: 7692286
[TBL] [Abstract][Full Text] [Related]
14. Impact of genotype on survival of children with T-cell acute lymphoblastic leukemia treated according to the French protocol FRALLE-93: the effect of TLX3/HOX11L2 gene expression on outcome.
Ballerini P; Landman-Parker J; Cayuela JM; Asnafi V; Labopin M; Gandemer V; Perel Y; Michel G; Leblanc T; Schmitt C; Fasola S; Hagemejier A; Sigaux F; Auclerc MF; Douay L; Leverger G; Baruchel A
Haematologica; 2008 Nov; 93(11):1658-65. PubMed ID: 18835836
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the results of the treatment of adolescents and young adults with standard-risk acute lymphoblastic leukemia with the Programa Español de Tratamiento en Hematología pediatric-based protocol ALL-96.
Ribera JM; Oriol A; Sanz MA; Tormo M; Fernández-Abellán P; del Potro E; Abella E; Bueno J; Parody R; Bastida P; Grande C; Heras I; Bethencourt C; Feliu E; Ortega JJ
J Clin Oncol; 2008 Apr; 26(11):1843-9. PubMed ID: 18398150
[TBL] [Abstract][Full Text] [Related]
16. Biology and treatment of acute lymphoblastic leukemia.
Pieters R; Carroll WL
Pediatr Clin North Am; 2008 Feb; 55(1):1-20, ix. PubMed ID: 18242313
[TBL] [Abstract][Full Text] [Related]
17. Biomarkers in long survivors of pediatric acute lymphoblastic leukemia patients: late effects of cancer chemotherapy.
Koishi S; Kubota M; Sawada M; Hirota H; Hashimoto H; Lin YW; Watanabe K; Usami I; Akiyama Y; Furusho K
Mutat Res; 1998 Dec; 422(2):213-22. PubMed ID: 9838123
[TBL] [Abstract][Full Text] [Related]
18. Somatic mutations at T-cell antigen receptor and glycophorin A loci in pediatric leukemia patients following chemotherapy: comparison with HPRT locus mutation.
Hirota H; Kubota M; Adachi S; Okuda A; Lin YW; Bessho R; Wakazono Y; Matsubara K; Kuwakado K; Akiyama Y
Mutat Res; 1994 Sep; 315(2):95-103. PubMed ID: 7521002
[TBL] [Abstract][Full Text] [Related]
19. Acute lymphoblastic leukemia in adolescents and young adults in Finland.
Usvasalo A; Räty R; Knuutila S; Vettenranta K; Harila-Saari A; Jantunen E; Kauppila M; Koistinen P; Parto K; Riikonen P; Salmi TT; Silvennoinen R; Elonen E; Saarinen-Pihkala UM
Haematologica; 2008 Aug; 93(8):1161-8. PubMed ID: 18556413
[TBL] [Abstract][Full Text] [Related]
20. Therapy-related changes in body size in Hispanic children with acute lymphoblastic leukemia.
Baillargeon J; Langevin AM; Lewis M; Grady JJ; Thomas PJ; Mullins J; Estrada J; Pitney A; Sacks N; Pollock BH
Cancer; 2005 Apr; 103(8):1725-9. PubMed ID: 15754333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
